ArticleFrontiers in immunology2026

Durable immunovirological control after sequential mogamulizumab and tucidinostat in relapsed or refractory adult T-cell leukemia/lymphoma.

Tatsuro Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.